查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1556656

連續壓片生產線市場報告：2030 年趨勢、預測與競爭分析

Continuous Tableting Line Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

連續壓片生產線趨勢與預測

預計 2024 年至 2030 年，全球連續壓片生產線市場將以 3.6% 的複合年成長率成長。該市場的主要驅動力是個人化醫療和複雜藥物配方的日益採用，以及外包製造的成長趨勢。全球連續壓片生產線市場前景廣闊，生物製藥、口服固態和保健食品市場充滿機會。

分段連續壓片生產線

本研究包括按類型、應用和地區對全球連續壓片生產線的預測。

連續壓片生產線市場洞察

根據Lucintel的預測，連續配方奶粉預計將在預測期內實現高速成長。

在這個市場中，生物製藥預計將經歷最高的成長。

在預測期內，北美仍將是最大的地區。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球連續壓片生產線市場預計將以3.6%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 該市場的主要驅動力是個人化醫療和複雜藥物配方的日益普及，以及製造外包的上升趨勢。

Q3.市場的主要細分市場是：

A3. 由於生物製藥、口服固體製劑和保健食品市場的機會，連續壓片生產線市場的未來性廣闊。

Q4.市場的主要企業是：

A4. 連續壓片生產線主要企業如下：

  • GEA
  • Hovione
  • Fette Compacting
  • IMA Pharma
  • Coperion K-Tron
  • KORSCH
  • Syntegon

Q5.未來最大的細分市場是什麼？

A5.Lucintel預測連續配方奶粉在預測期間內可望高速成長。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 在預測期內，北美仍將是最大的地區。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球連續壓片生產線市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球連續壓片生產線市場趨勢（2018-2023）與預測（2024-2030）
  • 全球連續壓片生產線市場（按類型）
    • 連續式
    • 半連續
  • 按應用分類的全球連續壓片生產線市場
    • 生物製藥
    • 口服固態劑型
    • 保健品
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球連續壓片生產線市場
  • 北美連續壓片生產線市場
  • 歐洲連續壓片生產線市場
  • 亞太連續壓片生產線市場
  • 其他地區連續壓片線市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球連續壓片生產線市場的成長機會：按類型
    • 全球連續壓片生產線市場的成長機會：依應用分類
    • 全球連續壓片生產線市場成長機會：按地區
  • 全球連續壓片線市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球連續壓片生產線市場的產能
    • 全球連續壓片生產線市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • GEA
  • Hovione
  • Fette Compacting
  • IMA Pharma
  • Coperion K-Tron
  • KORSCH
  • Syntegon
簡介目錄

Continuous Tableting Line Trends and Forecast

The future of the global continuous tableting line market looks promising with opportunities in the biopharmaceutical, oral solid dosage form, and health products markets. The global continuous tableting line market is expected to grow with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are growing adoption of personalized medicine and complex drug formulations and rising trend of outsourcing manufacturing.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Continuous Tableting Line by Segment

The study includes a forecast for the global continuous tableting line by type, application, and region.

Continuous Tableting Line Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Continuous
  • Semi-continuous

Continuous Tableting Line Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Biopharmaceutical
  • Oral Solid Dosage Form
  • Health Products
  • Others

Continuous Tableting Line Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Continuous Tableting Line Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies continuous tableting line companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the continuous tableting line companies profiled in this report include-

  • GEA
  • Hovione
  • Fette Compacting
  • IMA Pharma
  • Coperion K-Tron
  • KORSCH
  • Syntegon

Continuous Tableting Line Market Insights

Lucintel forecasts that continuous is expected to witness higher growth over the forecast period.

Within this market, biopharmaceutical is expected to witness the highest growth.

North America will remain the largest region over the forecast period.

Features of the Global Continuous Tableting Line Market

Market Size Estimates: Continuous tableting line market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Continuous tableting line market size by type, application, and region in terms of value ($B).

Regional Analysis: Continuous tableting line market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the continuous tableting line market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the continuous tableting line market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for continuous tableting line market?

Answer: The global continuous tableting line market is expected to grow with a CAGR of 3.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the continuous tableting line market?

Answer: The major drivers for this market are growing adoption of personalized medicine and complex drug formulations and rising trend of outsourcing manufacturing.

Q3. What are the major segments for continuous tableting line market?

Answer: The future of the continuous tableting line market looks promising with opportunities in the biopharmaceutical, oral solid dosage form, and health products markets.

Q4. Who are the key continuous tableting line market companies?

Answer: Some of the key continuous tableting line companies are as follows:

  • GEA
  • Hovione
  • Fette Compacting
  • IMA Pharma
  • Coperion K-Tron
  • KORSCH
  • Syntegon

Q5. Which continuous tableting line market segment will be the largest in future?

Answer: Lucintel forecasts that continuous is expected to witness higher growth over the forecast period.

Q6. In continuous tableting line market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the continuous tableting line market by type (continuous and semi-continuous), application (biopharmaceutical, oral solid dosage form, health products, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Continuous Tableting Line Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Continuous Tableting Line Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Continuous Tableting Line Market by Type
    • 3.3.1: Continuous
    • 3.3.2: Semi-continuous
  • 3.4: Global Continuous Tableting Line Market by Application
    • 3.4.1: Biopharmaceutical
    • 3.4.2: Oral Solid Dosage Form
    • 3.4.3: Health Products
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Continuous Tableting Line Market by Region
  • 4.2: North American Continuous Tableting Line Market
    • 4.2.1: North American Continuous Tableting Line Market by Type: Continuous and Semi-continuous
    • 4.2.2: North American Continuous Tableting Line Market by Application: Biopharmaceutical, Oral Solid Dosage Form, Health Products, and Others
  • 4.3: European Continuous Tableting Line Market
    • 4.3.1: European Continuous Tableting Line Market by Type: Continuous and Semi-continuous
    • 4.3.2: European Continuous Tableting Line Market by Application: Biopharmaceutical, Oral Solid Dosage Form, Health Products, and Others
  • 4.4: APAC Continuous Tableting Line Market
    • 4.4.1: APAC Continuous Tableting Line Market by Type: Continuous and Semi-continuous
    • 4.4.2: APAC Continuous Tableting Line Market by Application: Biopharmaceutical, Oral Solid Dosage Form, Health Products, and Others
  • 4.5: ROW Continuous Tableting Line Market
    • 4.5.1: ROW Continuous Tableting Line Market by Type: Continuous and Semi-continuous
    • 4.5.2: ROW Continuous Tableting Line Market by Application: Biopharmaceutical, Oral Solid Dosage Form, Health Products, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Continuous Tableting Line Market by Type
    • 6.1.2: Growth Opportunities for the Global Continuous Tableting Line Market by Application
    • 6.1.3: Growth Opportunities for the Global Continuous Tableting Line Market by Region
  • 6.2: Emerging Trends in the Global Continuous Tableting Line Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Continuous Tableting Line Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Continuous Tableting Line Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GEA
  • 7.2: Hovione
  • 7.3: Fette Compacting
  • 7.4: IMA Pharma
  • 7.5: Coperion K-Tron
  • 7.6: KORSCH
  • 7.7: Syntegon